PL3894410T3 - Podstawione pochodne ksantyny - Google Patents

Podstawione pochodne ksantyny

Info

Publication number
PL3894410T3
PL3894410T3 PL19820718.5T PL19820718T PL3894410T3 PL 3894410 T3 PL3894410 T3 PL 3894410T3 PL 19820718 T PL19820718 T PL 19820718T PL 3894410 T3 PL3894410 T3 PL 3894410T3
Authority
PL
Poland
Prior art keywords
xanthine derivatives
substituted xanthine
substituted
derivatives
xanthine
Prior art date
Application number
PL19820718.5T
Other languages
English (en)
Polish (pl)
Inventor
Kai Gerlach
Original Assignee
Boehringer Ingelheim International Gmbh
Hydra Biosciences, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International Gmbh, Hydra Biosciences, Llc filed Critical Boehringer Ingelheim International Gmbh
Publication of PL3894410T3 publication Critical patent/PL3894410T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL19820718.5T 2018-12-12 2019-12-10 Podstawione pochodne ksantyny PL3894410T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18212060 2018-12-12
PCT/EP2019/084375 WO2020120450A1 (en) 2018-12-12 2019-12-10 Substituted xanthine derivatives

Publications (1)

Publication Number Publication Date
PL3894410T3 true PL3894410T3 (pl) 2024-03-18

Family

ID=64665184

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19820718.5T PL3894410T3 (pl) 2018-12-12 2019-12-10 Podstawione pochodne ksantyny

Country Status (18)

Country Link
US (2) US11198696B2 (cg-RX-API-DMAC7.html)
EP (1) EP3894410B1 (cg-RX-API-DMAC7.html)
JP (1) JP7502299B2 (cg-RX-API-DMAC7.html)
KR (1) KR102877857B1 (cg-RX-API-DMAC7.html)
CN (1) CN113166151B (cg-RX-API-DMAC7.html)
AU (1) AU2019396499B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021008316A2 (cg-RX-API-DMAC7.html)
CL (1) CL2021001509A1 (cg-RX-API-DMAC7.html)
DK (1) DK3894410T3 (cg-RX-API-DMAC7.html)
EA (1) EA202191588A1 (cg-RX-API-DMAC7.html)
ES (1) ES2964630T3 (cg-RX-API-DMAC7.html)
HU (1) HUE064908T2 (cg-RX-API-DMAC7.html)
IL (1) IL283768B2 (cg-RX-API-DMAC7.html)
MX (1) MX2021007019A (cg-RX-API-DMAC7.html)
PH (1) PH12021551345A1 (cg-RX-API-DMAC7.html)
PL (1) PL3894410T3 (cg-RX-API-DMAC7.html)
TW (1) TWI825243B (cg-RX-API-DMAC7.html)
WO (1) WO2020120450A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12064917B2 (en) 2012-11-21 2024-08-20 Stratasys, Inc. Method for printing three-dimensional parts with cyrstallization kinetics control
IL283768B2 (en) * 2018-12-12 2024-05-01 Boehringer Ingelheim Int Xanthine histories are transmuted
KR20250141831A (ko) * 2023-02-08 2025-09-29 상하이 인스티튜트 오브 마테리아 메디카 차이니즈 아카데미 오브 싸이언시즈 잔틴계 화합물 및 이의 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX370372B (es) 2013-03-15 2019-12-11 Hydra Biosciences Inc Xantinas sustituidas y metodos de uso de las mismas.
EP3180340B1 (en) 2014-08-11 2018-10-10 Hydra Biosciences, Inc. Pyrido[2,3-d]pyrimidine-2,4(1h,3h)-dione derivatives
GB201702160D0 (en) 2017-02-09 2017-03-29 Univ Leeds Innovations Ltd Inhibitors for use in therapy
JP7114702B2 (ja) * 2017-07-11 2022-08-08 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規置換キサンチン誘導体
IL283768B2 (en) * 2018-12-12 2024-05-01 Boehringer Ingelheim Int Xanthine histories are transmuted

Also Published As

Publication number Publication date
HUE064908T2 (hu) 2024-04-28
ES2964630T3 (es) 2024-04-08
BR112021008316A2 (pt) 2021-08-03
KR20210102955A (ko) 2021-08-20
US11198696B2 (en) 2021-12-14
CN113166151A (zh) 2021-07-23
DK3894410T3 (da) 2023-11-27
IL283768A (en) 2021-07-29
CN113166151B (zh) 2023-12-01
TWI825243B (zh) 2023-12-11
JP7502299B2 (ja) 2024-06-18
CA3119229A1 (en) 2020-06-18
KR102877857B1 (ko) 2025-10-29
EP3894410B1 (en) 2023-10-11
EP3894410A1 (en) 2021-10-20
TW202039495A (zh) 2020-11-01
US20200190093A1 (en) 2020-06-18
MX2021007019A (es) 2021-09-10
IL283768B1 (en) 2024-01-01
US20220177479A1 (en) 2022-06-09
WO2020120450A1 (en) 2020-06-18
CL2021001509A1 (es) 2021-12-17
PH12021551345A1 (en) 2022-05-11
AU2019396499A1 (en) 2021-05-27
AU2019396499B2 (en) 2024-10-10
IL283768B2 (en) 2024-05-01
JP2022512373A (ja) 2022-02-03
EA202191588A1 (ru) 2021-10-18

Similar Documents

Publication Publication Date Title
IL283197A (en) Microbiocidal 2-acylamino-thiazole-4-carboxamide derivatives
PT3958977T (pt) Derivados de camptotecina
IL283333A (en) New heterocyclic compounds
IL292161A (en) New methylquinazolinone derivatives
LT3830085T (lt) Deuterinti lanifibranoro dariniai
PL3897842T3 (pl) Pochodne bicykliczne
DK3642202T3 (da) Dihydro-pyrrolo-pyridin-derivater
LT3768674T (lt) Aminopirimidino dariniai kaip ctps1 inhibitoriai
DK3810587T3 (da) Substituerede alkoxypyridinylindolsulfonamider
IL265166B (en) Anti-influenza virus pyrimidine derivatives
PL4013751T3 (pl) Pochodne 2-hydroksycykloalkano-1-karbamoilu
DK3768669T3 (da) Piperazinazaspiroderivater
LT3457851T (lt) Sobetiromo dariniai
EP4077334C0 (en) FUROINDAZOLE DERIVATIVES
LT3402792T (lt) Chinolin-2-ono dariniai
EP4021904C0 (en) ALPHA-D-GALACTOPYRANOSIDE DERIVATIVES
EP3862116A4 (en) Lathe
DK3823970T3 (da) Yderligere substituerede triazoloquinoxalinderivater
PL3898637T3 (pl) Pochodne rapamycyny
EP3885347A4 (en) DIHYDROPYRROLOPYRAZOLE DERIVATIVE
EP3884940A4 (en) Novel imidazole derivative
DK3823971T3 (da) Substituerede triazol-quinoxalin-derivater
DK3652176T3 (da) Substituerede xanthinderivater
DK3796975T3 (da) Sulfonylaminobenzamidderivater
DK3645513T3 (da) Benzazepinderivater